Correlation Engine 2.0
Clear Search sequence regions


  • GPCRs (1)
  • humans (1)
  • ligands (4)
  • receptor (20)
  • time factors (1)
  • Sizes of these terms reflect their relevance to your search.

    BACKGROUND AND PURPOSE The adenosine A(2A) receptor belongs to the superfamily of GPCRs and is a promising therapeutic target. Traditionally, the discovery of novel agents for the A(2A) receptor has been guided by their affinity for the receptor. This parameter is determined under equilibrium conditions, largely ignoring the kinetic aspects of the ligand-receptor interaction. The aim of this study was to assess the binding kinetics of A(2A) receptor agonists and explore a possible relationship with their functional efficacy. EXPERIMENTAL APPROACH We set up, validated and optimized a kinetic radioligand binding assay (a so-called competition association assay) at the A(2A) receptor from which the binding kinetics of unlabelled ligands were determined. Subsequently, functional efficacies of A(2A) receptor agonists were determined in two different assays: a novel label-free impedance-based assay and a more traditional cAMP determination. KEY RESULTS A simplified competition association assay yielded an accurate determination of the association and dissociation rates of unlabelled A(2A) receptor ligands at their receptor. A correlation was observed between the receptor residence time of A(2A) receptor agonists and their intrinsic efficacies in both functional assays. The affinity of A(2A) receptor agonists was not correlated to their functional efficacy. CONCLUSIONS AND IMPLICATIONS This study indicates that the molecular basis of different agonist efficacies at the A(2A) receptor lies within their different residence times at this receptor. © 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

    Citation

    Dong Guo, Thea Mulder-Krieger, Adriaan P IJzerman, Laura H Heitman. Functional efficacy of adenosine A₂A receptor agonists is positively correlated to their receptor residence time. British journal of pharmacology. 2012 Jul;166(6):1846-59

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 22324512

    View Full Text